(Q33320985)

25 July 2017

1 reference

title

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma (English)

1 reference

25 July 2017

0 references

0 references

1 reference

1

Yataro Daigo

1 reference

25 July 2017

Yusuke Nakamura

2

1 reference

25 July 2017

publication date

24 February 2008

1 reference

General thoracic and cardiovascular surgery

25 July 2017

published in

1 reference

25 July 2017

volume

56

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

43-53

1 reference

Transducible peptide therapy for uveal melanoma and retinoblastoma

25 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11748-007-0211-X

ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway

21 January 2018

1 reference

12 December 2020

Expression profiles of two types of human knee-joint cartilage

1 reference

12 December 2020

Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers

1 reference

12 December 2020

Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.

1 reference

12 December 2020

Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray

1 reference

12 December 2020

Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.

1 reference

12 December 2020

Chemoprevention of aerodigestive cancer

1 reference

12 December 2020

Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas

1 reference

12 December 2020

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

12 December 2020

Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis

1 reference

12 December 2020

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

1 reference

12 December 2020

Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma

1 reference

12 December 2020

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas

1 reference

12 December 2020

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

12 December 2020

A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis

1 reference

12 December 2020

Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer

1 reference

12 December 2020

Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas

1 reference

12 December 2020

Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trials

1 reference

12 December 2020

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

1 reference

12 December 2020

Identification of COX17 as a therapeutic target for non-small cell lung cancer

1 reference

12 December 2020

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

ADAM8 as a novel serological and histochemical marker for lung cancer

1 reference

12 December 2020

Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer

1 reference

12 December 2020

CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation

1 reference

12 December 2020

Cancer Tumor antigens

1 reference

12 December 2020

The cancer/testis genes: review, standardization, and commentary.

1 reference

12 December 2020

The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer

1 reference

12 December 2020

Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy

1 reference

12 December 2020

Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer

1 reference

12 December 2020

Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis

1 reference

12 December 2020

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience

1 reference

12 December 2020

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

12 December 2020

Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer

1 reference

12 December 2020

Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray.

1 reference

12 December 2020

Erlotinib in previously treated non-small-cell lung cancer

1 reference

12 December 2020

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer

1 reference

12 December 2020

Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice

1 reference

12 December 2020

Global cancer statistics in the year 2000.

1 reference

12 December 2020

Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer

1 reference

12 December 2020

Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis

1 reference

12 December 2020

Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells

1 reference

12 December 2020

CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

12 December 2020

10.1007/S11748-007-0211-X

Identifiers

DOI

1 reference

25 July 2017

1 reference